Literature DB >> 14509155

Risk factors for carriage of group B streptococcus in southern Israel.

Dror Marchaim1, Mordechai Hallak, Limor Gortzak-Uzan, Nechama Peled, Klaris Riesenberg, Francisc Schlaeffer.   

Abstract

BACKGROUND: In southern Israel, a discrepancy between a relatively high prevalence of Group B streptococcus maternal carriage (12.3%) and a very low incidence of neonatal disease (0.1/1,000 live births) has been found despite the fact that no preventive strategy has been implemented.
OBJECTIVES: To determine the risk factors for maternal carriage in order to clarify this discrepancy and further examine the different aspects of GBS in southern Israel.
METHODS: Cultures for GBS were obtained from 681 healthy pregnant women, and relevant demographic and obstetric data were collected. The medical records of 86 neonates born to carrier women were retrospectively examined. Statistical analysis was performed using the Pearson chi-square test.
RESULTS: Women who were not born in Israel, particularly immigrants from the former USSR, were significantly prone to carry the pathogen compared to native Israeli women (Bedouins and Jews) (P = 0.03).
CONCLUSIONS: A high GBS transmission rate is expected among immigrants who came from areas with a high prevalence of maternal carriage to one with a low incidence of neonatal disease environment and were not subject to any preventive strategy. Clinical attention should be directed to this issue throughout Israel.

Entities:  

Mesh:

Year:  2003        PMID: 14509155

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  5 in total

1.  Clonal variability of group B Streptococcus among different groups of carriers in southern Israel.

Authors:  D Marchaim; S Efrati; R Melamed; L Gortzak-Uzan; K Riesenberg; R Zaidenstein; F Schlaeffer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-07       Impact factor: 3.267

2.  The relationship between the new taxonomy of Streptococcus bovis and its clonality to colon cancer, endocarditis, and biliary disease.

Authors:  T Lazarovitch; M Shango; M Levine; R Brusovansky; R Akins; K Hayakawa; P R Lephart; J D Sobel; K S Kaye; D Marchaim
Journal:  Infection       Date:  2012-08-11       Impact factor: 3.553

3.  While waiting for a vaccine: opportunities for optimization of neonatal group B streptococcal (GBS) disease prevention in Israel.

Authors:  Dan Waisman; Ayala Gover; Michal Molad; Reuven Kedar; Avi Rotschild; William E Benitz
Journal:  J Perinatol       Date:  2018-12-11       Impact factor: 2.521

4.  Group B streptococcus serotype prevalence in reproductive-age women at a tertiary care military medical center relative to global serotype distribution.

Authors:  Danielle L Ippolito; Wesley A James; Deborah Tinnemore; Raywin R Huang; Mary J Dehart; Julie Williams; Mark A Wingerd; Samandra T Demons
Journal:  BMC Infect Dis       Date:  2010-11-24       Impact factor: 3.090

5.  Streptococcus agalactiae in childbearing age immigrant women in Comunitat Valenciana (Spain).

Authors:  José Miguel Sahuquillo-Arce; Alicia Hernández-Cabezas; María Jesús Castaño-Aroca; Rabab Chouman-Arcas; Estefanía Díaz-Aguirre; Beatriz Acosta-Boga; José Luis López-Hontangas
Journal:  Sci Rep       Date:  2020-06-18       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.